NewsEvents

Your Yourlocation: Home > Clinical observation of tiotropium bromide(136310-93-5) combined with seretide in the treatment of chronic obstructive pulmonary disease

The first Affiliated Hospital of Guangxi University of Science and Technology Lu Wei et al. studied the clinical efficacy of tiotropium bromide(136310-93-5) and sulidide in the treatment of chronic obstructive pulmonary disease, the study found that the use of tiotropium and sulidide treatment of COPD its clinical effect is better than Seretide alone, but also can effectively improve the patient sputum, shortness of breath and other clinical symptoms, improve lung function, is worthy of clinical use. The article published in 2016 03 "medical theory and practice".

The aim of this study was to analyze the clinical efficacy of tiotropium bromide(136310-93-5) plus sulidazole in the treatment of chronic obstructive pulmonary disease (COPD).

METHODS: A total of 486 COPD patients admitted to our hospital from February 2012 to June 2014 were randomly divided into experimental group and control group. 226 patients in the control group were treated with seretide and 260 patients in the experimental group. The therapeutic effects of tiotropium bromide(136310-93-5) and sulindol were compared.

The results showed that two groups of blood gas analysis before treatment no difference in the experimental group after treatment was significantly improved, the difference was statistically significant. In the experimental group, the improvement of pulmonary ventilation function was significantly improved with tiotropium bromide(136310-93-5) combined with seretide in control group. The total effective rate of the treatment group was 96.15%, which was significantly higher than that of the control group (85.40%), the difference was statistically significant (P <0.05).

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved